1) a paired designed trial
临床配对试验
1.
Preliminary application of implant unit in alveolus surgery:a paired designed trial;
种植机在牙槽外科初步应用的临床配对试验研究
2) Controlled clinical trials
临床对照试验
1.
Controlled clinical trials on the effects of Chinese traditional medicine for the treatment of osteoarthritis of knee joint at early stage and its MRI changes;
中医辨证施治对早期膝骨关节炎疗效及关节软骨MRI影响的临床对照试验
2.
Controlled clinical trials on the pathological expressions of VEGF in patients with active ankylosing spondylitis;
血管内皮生长因子在强直性脊柱炎活动期病理性表达的临床对照试验
3.
Controlled clinical trials of therapeutic effects of Chinses herbs promoting blood circulation and removing blood stasis on the treatment of reflex sympathetic dystrophy with type of stagnation of vital energy and blood stasis
活血化瘀法治疗气滞血瘀型反射性交感神经营养不良的临床对照试验
3) Controlled clinical trial
临床对照试验
1.
Controlled clinical trials of external using of Cheezheng Qingpeng ointment (奇正青鹏膏) on reliving analgesia and swelling for the treatment of rheumatoid arthritis
奇正青鹏膏剂外用治疗类风湿关节炎止痛消肿作用的临床对照试验
4) Clinical controlled trial
临床对照试验
1.
Purpose: This study was to evaluate the current situation of therapeutic and randomized controlled trials/clinical controlled trials(RCT/CCT) on acute pancreatitis(AP) in China according to Evidence-Based Medicine(EBM), in order to understand whether treatment and clinical research and design of AP was reasonable, and it could offer reliable evidence for clinical practice.
目的:本研究从循证医学(EBM)的角度对我国主要中文期刊中有关急性胰腺炎(AP)治疗性研究的随机对照试验/临床对照试验(RCT/CCT)文章进行分析,旨在了解AP 的治疗和临床科研设计是否合理,是否能向临床提供可靠的证据。
6) clinical trial
临床试验
1.
EMEA's consideration on strategy and design of clinical trials for new antibacterial agent;
欧盟医药管理局对新抗菌药物临床试验策略和设计的考虑
2.
FDA's general considerations on the antibacterial dugs clinical trial protocol issues and its enlightenment;
美国FDA对抗菌药物临床试验方案的考虑及其借鉴
3.
FDA's considerations of non-inferiority design used in anti-bacterial drug clinical trials;
美国FDA对抗菌药物临床试验非劣效设计的考虑
补充资料：临床试验
分子式：
CAS号：
性质：新药的临床试验一般分三期或四期进行。多数国家按四期进行。工期临床试验(phase工Clinical trials)是在人体进行新药试验的起始期。包括药物耐受性(toierance)试验与药代动力学(pharmacokinetics)，生物利用度(bioavailability)研究。Ⅱ期临床试验(phaseⅡ clinicaltrials)要对新药的疗效、适应症、不良反应进行详细考察。通过随机对照临床试验对新药的安全有效性作出确切评价。III期临床试验(phase III clinical trials)为扩大临床试验，目的是在较大范围内对新药的疗效、适应症、不良反应、药物相互作用等进行评价。Ⅳ临床试验(phase IV clinical trials)是在新药投产后进行的，为上市后临床试验或称为上市后药物监察(postmarketing surveillance)。目的是对已在临床广泛应用的新药进行社会性考察，着重于新药的不良反应监察(ad-Verse drug reaction surveillance)。
CAS号：
性质：新药的临床试验一般分三期或四期进行。多数国家按四期进行。工期临床试验(phase工Clinical trials)是在人体进行新药试验的起始期。包括药物耐受性(toierance)试验与药代动力学(pharmacokinetics)，生物利用度(bioavailability)研究。Ⅱ期临床试验(phaseⅡ clinicaltrials)要对新药的疗效、适应症、不良反应进行详细考察。通过随机对照临床试验对新药的安全有效性作出确切评价。III期临床试验(phase III clinical trials)为扩大临床试验，目的是在较大范围内对新药的疗效、适应症、不良反应、药物相互作用等进行评价。Ⅳ临床试验(phase IV clinical trials)是在新药投产后进行的，为上市后临床试验或称为上市后药物监察(postmarketing surveillance)。目的是对已在临床广泛应用的新药进行社会性考察，着重于新药的不良反应监察(ad-Verse drug reaction surveillance)。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条